LLY ▼ -0.4% - Eli Lilly and Company $LLY - U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes 24-SEP-2026 06:45 AM ET